|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Zogenix, Inc.
| | | Phone: | (510) 550-8300 | Fax: | (510) 550-8340 | Year Established: | 2006 | Ticker: | ZGNX | Exchange: | NASDAQ | Main Contact: | Gail M. Farfel, Ph.D., CDO | | Other Contacts: | John J. Turanin, VP, Operations Stephen H. Jenner, VP, Marketing Mark R. Thompson, VP, Sales & Managed Markets Bret E. Megargel, VP, Corporate Development Stephen J. Farr, Ph.D., President & COO Michael P. Smith, Executive VP & CFO Roger L. Hawley, CEO & CCO Ashish Sagrolikar, CCO
| | Company Description | Zogenix is committed to developing and commercializing therapies for central nervous system disorders that address specific clinical needs for people living with orphan diseases and other CNS disorders who need innovative treatment alternatives to improve their daily functioning. | |
|
|
|
|
|